Companies included in XPH
This is XPH's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–62 of 62.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| State Street Global Advisors | State Street Global Advisors | 24,400,789 | NS | 7.925785% |
| ELVN | Enliven Therapeutics Inc | 192,297 | NS | 2.448482% |
| CORT | Corcept Therapeutics Inc | 174,971 | NS | 2.290959% |
| Terns Pharmaceuticals Inc | Terns Pharmaceuticals Inc | 126,197 | NS | 2.16104% |
| PRGO | Perrigo Co PLC | 601,785 | NS | 2.099346% |
| AXSM | Axsome Therapeutics Inc | 37,013 | NS | 2.032033% |
| INVA | Innoviva Inc | 263,314 | NS | 1.992821% |
| MRK | Merck & Co Inc | 50,800 | NS | 1.984868% |
| PFE | Pfizer Inc | 216,247 | NS | 1.972357% |
| RPRX | Royalty Pharma PLC | 126,441 | NS | 1.970135% |
| ELAN | Elanco Animal Health Inc | 251,749 | NS | 1.956811% |
| JAZZ | Jazz Pharmaceuticals PLC | 31,838 | NS | 1.955064% |
| Esperion Therapeutics Inc | Esperion Therapeutics Inc | 2,194,800 | NS | 1.953367% |
| EWTX | Edgewise Therapeutics Inc | 190,497 | NS | 1.949113% |
| MBX | MBX Biosciences Inc | 200,744 | NS | 1.94637% |
| DFTX | Definium Therapeutics Inc | 316,882 | NS | 1.94535% |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | 98,425 | NS | 1.938986% |
| ANIP | ANI Pharmaceuticals Inc | 77,382 | NS | 1.932879% |
| JNJ | Johnson & Johnson | 24,295 | NS | 1.928979% |
| TARS | Tarsus Pharmaceuticals Inc | 84,481 | NS | 1.924975% |
| TRVI | Trevi Therapeutics Inc | 494,432 | NS | 1.915956% |
| PCRX | Pacira BioSciences Inc | 258,586 | NS | 1.898243% |
| ZTS | Zoetis Inc | 49,282 | NS | 1.892261% |
| CRNX | Crinetics Pharmaceuticals Inc | 159,642 | NS | 1.883352% |
| NKTR | Nektar Therapeutics | 80,506 | NS | 1.881471% |
| LQDA | Liquidia Corp | 153,099 | NS | 1.876777% |
| AMRX | Amneal Pharmaceuticals Inc | 464,477 | NS | 1.875313% |
| HRMY | Harmony Biosciences Holdings Inc | 205,054 | NS | 1.865605% |
| SUPN | Supernus Pharmaceuticals Inc | 110,926 | NS | 1.862423% |
| VTRS | Viatris Inc | 422,585 | NS | 1.854419% |
| XERS | Xeris Biopharma Holdings Inc | 975,649 | NS | 1.838061% |
| HROW | Harrow Inc | 159,813 | NS | 1.830344% |
| OGN | Organon & Co | 922,423 | NS | 1.794714% |
| NUVB | Nuvation Bio Inc | 1,286,168 | NS | 1.792229% |
| PAHC | Phibro Animal Health Corp | 99,625 | NS | 1.789824% |
| AMLX | Amylyx Pharmaceuticals Inc | 395,413 | NS | 1.785271% |
| INDV | Indivior Pharmaceuticals Inc | 179,821 | NS | 1.780302% |
| COLL | Collegium Pharmaceutical Inc | 165,736 | NS | 1.780285% |
| LLY | Eli Lilly & Co | 5,904 | NS | 1.76386% |
| PBH | Prestige Consumer Healthcare Inc | 91,089 | NS | 1.753635% |
| Ligand Pharmaceuticals Inc | Ligand Pharmaceuticals Inc | 26,684 | NS | 1.730448% |
| OCUL | Ocular Therapeutix Inc | 621,423 | NS | 1.709658% |
| OMER | Omeros Corp | 494,846 | NS | 1.697354% |
| EYPT | EyePoint Inc | 395,677 | NS | 1.656655% |
| ALMS | Alumis Inc | 224,127 | NS | 1.603788% |
| AMPH | Amphastar Pharmaceuticals Inc | 227,681 | NS | 1.448771% |
| PHAT | Phathom Pharmaceuticals Inc | 398,901 | NS | 1.43952% |
| TBPH | Theravance Biopharma Inc | 268,815 | NS | 1.417132% |
| RAPP | Rapport Therapeutics Inc | 134,504 | NS | 1.367034% |
| ARVN | Arvinas Inc | 362,073 | NS | 1.246638% |
| CRMD | CorMedix Inc | 554,307 | NS | 1.222527% |
| BIOA | BioAge Labs Inc | 210,974 | NS | 1.198553% |
| MAZE | Maze Therapeutics Inc | 117,041 | NS | 1.134804% |
| SEPN | Septerna Inc | 128,633 | NS | 1.004025% |
| WVE | WaVe Life Sciences Ltd | 419,283 | NS | 0.987379% |
| ZVRA | Zevra Therapeutics Inc | 324,871 | NS | 0.983479% |
| FULC | Fulcrum Therapeutics Inc | 367,717 | NS | 0.91611% |
| AQST | Aquestive Therapeutics Inc | 600,305 | NS | 0.809205% |
| LBRX | LB Pharmaceuticals Inc | 89,202 | NS | 0.714506% |
| ANRO | Alto Neuroscience Inc | 73,288 | NS | 0.53514% |
| State Street Global Advisors | State Street Global Advisors | 257,195.72 | NS | 0.083541% |
| State Street Global Advisors | State Street Global Advisors | 5,482.12 | NS | 0.001781% |
SEC N-PORT snapshot as of .